The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome. (Blood, 2010)

(untitled) - Driscoll, J; Pelluru, D; Lefkimmiatis, K; Fulciniti, M; Prabhala, R; Greipp, P; Barlogie, B; Tai, Y; Anderson, K; Shaughnessy, J; Annunziata, C; Munshi, N